Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers.
- DOI
- 10.1016/j.nbd.2026.107605
- Published
- 2026 Sep 13
- Container
- Neurobiology of disease
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.nbd.2026.107605,
title = {Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers.},
author = {Johnson AK and Van Hulle CA and Zylstra H and Cronin K and Johnson K and Rivera-Rivera L and Chappell R and Wilson R and Kac PR and Gleason CE and Zetterberg H and Johnson SC and Auger AP and Carlsson CM},
year = {2026},
journal = {Neurobiology of disease},
doi = {10.1016/j.nbd.2026.107605},
url = {https://doi.org/10.1016/j.nbd.2026.107605}
}RIS
TY - JOUR TI - Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers. AU - Johnson AK AU - Van Hulle CA AU - Zylstra H AU - Cronin K AU - Johnson K AU - Rivera-Rivera L AU - Chappell R AU - Wilson R AU - Kac PR AU - Gleason CE AU - Zetterberg H AU - Johnson SC AU - Auger AP AU - Carlsson CM PY - 2026 JO - Neurobiology of disease DO - 10.1016/j.nbd.2026.107605 UR - https://doi.org/10.1016/j.nbd.2026.107605 ER -
APA
AK, J., CA, V. H., H, Z., K, C., K, J., L, R., R, C., R, W., PR, K., CE, G., H, Z., SC, J., AP, A., & CM, C. (2026). Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers.. Neurobiology of disease. https://doi.org/10.1016/j.nbd.2026.107605
Source records
- pubmed · retrieved 2026-09-25T14:38:54.899Z
- europe-pmc · retrieved 2026-09-25T14:38:54.910Z